Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours.
about
The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agentsPhase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumoursInhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations.Population pharmacokinetic analysis of axitinib in healthy volunteers.Clinical pharmacology of axitinib.Axitinib for the treatment of advanced renal cell carcinoma.Practical guidelines for therapeutic drug monitoring of anticancer tyrosine kinase inhibitors: focus on the pharmacokinetic targets.Receptor tyrosine kinase inhibitors: Are they real tumor killers?Axitinib: from preclinical development to future clinical perspectives in renal cell carcinoma.Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review.Impact of pazopanib on docetaxel exposure: results of a phase I combination study with two different docetaxel schedules.Pharmacokinetic-Guided Dosing of New Oral Cancer Agents.
P2860
Q33872751-C4F6B485-DCF1-4B8E-9C18-9F709578E5B3Q36387910-266B626B-9118-48D4-942C-AA80512598D1Q37594395-08FCE4A3-C422-407A-8EBD-498546AD3E54Q37635202-1D80A2C1-A6A7-48BD-A127-E89A817D9148Q38107175-4E8CDAA8-DEEA-4CE9-B860-DEDF6B7B5F89Q38170397-7E1FC4C8-6E5E-4197-91F0-3525D697FE2DQ38190857-88454FCF-304C-4FB0-9154-84D6DD0BACA1Q38365290-E0DEC620-997B-475A-AECC-4E59E98A7DD9Q38514440-E0E73D83-B705-4DF9-B38F-013B7A6431AEQ38726616-5D963A7F-73FA-4AC6-8FEB-4F70788D24B4Q41658065-72CD5A08-24D9-4362-ADD8-94A310647A55Q47969048-F05B0566-7463-4FA8-B121-5E57E14B6EBA
P2860
Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Phase I study of axitinib comb ...... s with advanced solid tumours.
@ast
Phase I study of axitinib comb ...... s with advanced solid tumours.
@en
type
label
Phase I study of axitinib comb ...... s with advanced solid tumours.
@ast
Phase I study of axitinib comb ...... s with advanced solid tumours.
@en
prefLabel
Phase I study of axitinib comb ...... s with advanced solid tumours.
@ast
Phase I study of axitinib comb ...... s with advanced solid tumours.
@en
P2093
P2860
P356
P1476
Phase I study of axitinib comb ...... s with advanced solid tumours.
@en
P2093
A J Olszanski
B Rosbrook
L P Martin
M F Kozloff
M Tortorici
R S Herbst
P2860
P2888
P304
P356
10.1038/BJC.2012.407
P407
P577
2012-09-20T00:00:00Z